Antimüllerian hormone (amh) not only a marker for prediction of ovarian reserve

Physiological Research

Volumn 60, Issue 2, 2011, Pages 217-223

  Hampl, R ^a   Snajderova M ^b   Mardesic T ^c  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c Sanatorium Pronatal   (Czech Republic)

Author keywords

Antim llerian hormone; Male development; Pathophysiology; Physiological function; Reproduction

Indexed keywords

EID: 79959199911     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932076     Document Type: Review

References (24)

1. CHANG HL, PAHLAVAN N, HALPERN EF, MACLAUGHLIN DT: Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecol Oncol 114: 57-60, 2009.
2. CHEN MJ, YANG WS, CHEN CL, WU MY, YANG YS, HO HN: The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 23: 952-957, 2008.
3. DI CLEMENTE N, BELVILLE C: Anti-Müllerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 20: 599-610, 2006.
4. ELDAR-GEVA T, LIBERTY G, CHERTIN B, FRIDMANS A, FARKAS A, MARGALIOTH EJ, SPITZ IM: Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancer. Eur J Endocrinol 162: 177-181, 2010.
5. FRÉOUR T, MIRALLIÉ S, BACH-NGOHOU K, DENIS M, BARRIÈRE P, MASSON D: Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 375: 162-164, 2007.
6. GEERTS I, VERGOTE I, NEVEN P, BILLEN J: The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors. Int J Gynecol Cancer 19: 847-855, 2009.
7. GRINSPON RP, REY RA: Anti-müllerian hormone and Sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr 73: 81-92, 2010.
8. HAMPL R, STÁRKA L: Sex hormone-binding globulin in endocrine regulation (minireview). Endocr Regul 30: 57-65, 1996.
9. KAYA C, PABUCCU R, SATIROGLU H: Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction. Fertil Steril 94: 2202-2207, 2010.
10. KEVENAAR ME, LAVEN JS, FONG SL, UITTERLINDEN AG, DE JONG FH, THEMMEN AP, VISSER JA: A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab 93: 1310-1306, 2008.
11. KNAUFF EA, EIJKEMANS MJ, LAMBALK CB, TEN KATE-BOOIJ MJ, HOEK A, BEERENDONK CC, LAVEN JS, GOVERDE AJ, BROEKMANS FJ, THEMMEN AP, DE JONG FH, FAUSER BC; DUTCH PREMATURE OVARIAN FAILURE CONSORTIUM: Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 94: 786-792, 2009.
12. LA MARCA A, BROEKMANS FJ, VOLPE A, FAUSER BC, MACKLON NS; ESHRE SPECIAL INTEREST GROUP FOR REPRODUCTIVE ENDOCRINOLOGY-AMH ROUND TABLE: Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 24: 2264-2275, 2009
13. LA MARCA A, VOLPE A: Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol (Oxf) 64: 603-610, 2006
14. LA MARCA A, VOLPE A: The Anti-Mullerian hormone and ovarian cancer. Hum Reprod Update 13: 265-273, 2007.
15. LAVEN JS, MULDERS AG, VISSER JA, THEMMEN AP, DE JONG FH, FAUSER BC: Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89: 318-323, 2004.
16. NARDO LG, YATES AP, ROBERTS SA, PEMBERTON P, LAING I: The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 24: 2917-2923, 2009.
17. PARK AS, LAWSON MA, CHUAN SS, OBERFIELD SE, HOEGER KM, WITCHEL SF, CHANG RJ: Serum antimullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism. J Clin Endocrinol Metab 95: 1786-1792, 2010.
18. PARK HT, CHO GJ, AHN KH, SHIN JH, KIM YT, HUR JY, KIM SH, LEE KW, KIM T: Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 72: 26-31, 2010.
19. PELLATT L, RICE S, MASON H: Anti-Mullerian hormone and polycystic ovary syndrome: A mountain too high? Reproduction 139: 825-833, 2010
20. PICARD JY, BELVILLE C: Genetics and molecular pathology of anti-Mullerian hormone and its receptor. J Soc Biol 196: 217-221, 2002.
21. REY RA, MUSSE M, VENARA M, CHEMES HE: Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech 72: 787-795, 2009.
22. SPROUL K, JONES MR, MATHUR R, AZZIZ R, GOODARZI MO: Association study of four key folliculogenesis genes in polycystic ovary syndrome. BJOG 117: 756-760, 2010.
23. VAN BEEK RD, VAN DEN HEUVEL-EIBRINK MM, LAVEN JS, DE JONG FH, THEMMEN AP, HAKVOORTCAMMEL FG, VAN DEN BOS C, VAN DEN BERG H, PIETERS R, DE MUINCK KEIZER-SCHRAMA SM: Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 92: 3869-3874, 2007.
24. VISSER JA, DE JONG FH, LAVEN JS, THEMMEN AP: Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 131: 1-9, 2006.